Mandate

Vinge advised LumenRadio AB (publ) in connection with the listing on Nasdaq First North Growth Market

Vinge has advised LumenRadio AB (publ) (“LumenRadio”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 28 November 2022 and the first day of trading occurred on 8 December 2022.

The offering in connection with the listing was conducted at a fixed price of SEK 48 per share, corresponding to a market value for LumenRadio’s shares of approximately SEK 544 million before the offering and approximately SEK 594 million after the completion of the offering.

LumenRadio is a Gothenburg based technology company focusing on developing and selling reliable wireless product-to-product connections for business-critical applications within the Internet of Things (“IoT”). LumenRadio offers scalable solutions that build on proprietary and patented technology for future-proof wireless data transfer on open frequency bands, replacing traditional cables for control and automation. LumenRadio has around 60 employees and is headquartered in Gothenburg, with two small sales offices in Frankfurt and Boston.

Vinge’s team primarily consisted of Magnus Pauli, Edin Agic (Project Manager), Petronella Hallberg, Adrian Filipovic, Amelia Rihs, Hanna Jansson (Capital Markets and Public M&A), Anna Högsten, Victoria Gunnerek (Employment and Sanctions) and Amanda Stoltz (VDR).

 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025